Tag: Market Access

Four Market Access Measures Triggered by COVID-19 That Are Here To Stay

Many market access decisions were intended to provide rapid one-off answers to one of the most extraordinary situations healthcare systems have ever had to face, but some of them are telling us something about the more profound changes that are likely to affect pharmaceutical market access in the longer run.

Market Access Activity Impact from the Initial months of the COVID-19 Pandemic

Reflections on The Initial Impact of COVID-19 on Global Market Access Activities

Inbeeo dives into the data from our COVID-19 Impact on Market Access Activities Dashboard and identifies three positive trends that emerged.

What pharmaceutical companies can do to for payers to help their healthcare technologies achieve Market Access

Ask Not What Payers Can Do for You – Ask What You Can Do for Payers

Five tips worth keeping mind when planning for market access. An infographic.

Care Affordability Index or How to Go Beyond the “# of Lives Covered” Metric

A Care Affordability Index could constitute a way more informative measure of patient-access performance than the binary “number of lives covered”. And it is not that complicated to implement. A post for dashboard lovers.

Menu

Tag: Market Access

Four Market Access Measures Triggered by COVID-19 That Are Here To Stay

Reflections on The Initial Impact of COVID-19 on Global Market Access Activities

Ask Not What Payers Can Do for You – Ask What You Can Do for Payers

Care Affordability Index or How to Go Beyond the “# of Lives Covered” Metric

Get started with Inbeeo and realise the true value of your assets.

Quick Access

Hours & Info